Reply: Cost of Therapies in Acute Coronary Syndromes: A Relevant Factor Not Reflected in the Trials

Free article

Comment

Zuzana Motovska et al. J Am Coll Cardiol. 2018.

Free article

. 2018 Jun 12;71(23):2711-2712.

doi: 10.1016/j.jacc.2018.04.002.

No abstract available

Comment on

1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor.
Motovska Z, Hlinomaz O, Kala P, Hromadka M, Knot J, Varvarovsky I, Dusek J, Jarkovsky J, Miklik R, Rokyta R, Tousek F, Kramarikova P, Svoboda M, Majtan B, Simek S, Branny M, Mrozek J, Cervinka P, Ostransky J, Widimsky P; PRAGUE-18 Study Group. Motovska Z, et al. J Am Coll Cardiol. 2018 Jan 30;71(4):371-381. doi: 10.1016/j.jacc.2017.11.008. Epub 2017 Nov 14. J Am Coll Cardiol. 2018. PMID: 29154813 Clinical Trial.
Cost of Therapies in Acute Coronary Syndromes: A Relevant Factor Not Reflected in the Trials.
Lozano I, Lopez-Palop R, Garcia Rubio J, Cordero A. Lozano I, et al. J Am Coll Cardiol. 2018 Jun 12;71(23):2710. doi: 10.1016/j.jacc.2018.02.081. J Am Coll Cardiol. 2018. PMID: 29880137 No abstract available.